Loading...
Chemical structure of AM4113

GC15093

AM4113

Also known as 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide

AM4113 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25·5 nM

ChemicalCAS614726-85-1MW380.7FormulaC17H12Cl3N3O
CAS number
614726-85-1
Molecular weight
380.7
Formula
C17H12Cl3N3O
Solubility
≤0·5mg/ml in ethanol;3mg/ml in DMSO;10mg/ml in dimethyl formamide
InChIKey
BBUKVPCUOHFAQN-UHFFFAOYSA-N
Catalogue number
GC15093
Brand
GLPBIO
Computed properties PubChem CID 66844170 · XLogP 5 · TPSA 60.9 Ų · H-bond donors 1
XLogP
5
TPSA
60.9 Ų
H-bond donors
1
H-bond acceptors
2
Rotatable bonds
3
Heavy atoms
24

SMILES CC1=C(N(N=C1C(=O)N)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)Cl

Computed descriptors from PubChem (CID 66844170), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.